Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03489421 · ClinicalTrials.gov registry record
Mitochondria in HIV and Aging (MITO+)
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 14
- Enrollment target
NCT03489421 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 14 participants.
The verdict
NCT03489421 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
Older adults with human immunodeficiency virus (HIV) and a long history of antiretroviral therapy have more mitochondrial dysfunction- the cells that help them make energy. This dysfunction in mitochondria may lead to symptoms of muscle fatigue, physical function impairment, and impaired exercise tolerance compared to HIV-uninfected controls of a similar age and body mass index (BMI). Furthermore, the investigators hypothesize that the older antiretroviral therapy (ART) of tenofovir disoproxil fumarate (TDF) is associated with greater impairment in mitochondrial function than the newer agent, tenofovir alafenamide (TAF).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-12-15 |
| Est. Completion | 2019-09-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03489421
The ClinicalTrials.gov registry entry for NCT03489421 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03489421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03489421 about?
NCT03489421 is a clinical study titled "Mitochondria in HIV and Aging (MITO+)". Older adults with human immunodeficiency virus (HIV) and a long history of antiretroviral therapy have more mitochondrial dysfunction- the cells that help them make energy. This dysfunction in mitochondria may lead to symptoms of muscle fatigue, physical function impairment, and impaired exercise to...
What is the current status of trial NCT03489421?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2018-12-15. Estimated completion is 2019-09-05.
Who is sponsoring clinical trial NCT03489421?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.